Profile cover photo
Profile photo
Harlem Biospace
A new biotech incubator concept, right in Manhattan
A new biotech incubator concept, right in Manhattan

Harlem Biospace's posts

Post has attachment

Post has attachment

Post has attachment
HYPOTHEkids (Hk) is the K-12 STEM initiative of Harlem Biospace.  Our mission is to connect students in underserved communities in NYC to today’s most cutting-edge biomedical science.  This summer we will launch the Hk Maker Lab.  The Hk Maker Lab is an intense six-week summer program to learn the foundations of design. Focusing on addressing a global health problem, the students will prototype and test a biomedical device and develop an associated business plan.  The program will culminate in a presentation to leading executives from the biomedical community.  The Hk Maker Lab projects might then be incubated using the state-of-the-art facilities at Harlem Biospace.
The Hk Maker Lab will be open to students across NYC that come from high schools where over 50% of students qualify for free or reduced price lunch or the student himself/herself qualifies for free or reduced price lunch.   24-28 students will participate in our first Hk Maker Lab, which will be hosted at Columbia University from July 14th to August 22nd, 2014.

Post has attachment
Interesting profile of some of our member companies: 

Post has attachment
Hb's K-12 STEM program is one of Cognizant's Making the Future grant awardees. We will be doing some very exciting things with the Hk Maker Lab. 

Post has attachment
Check out this article on the designers behind Hb

Post has attachment
Traditional paradigms of drug screening often focus solely on single targets or pathways.  To improve the drug discovery process, cellular imaging techniques have been developed that would allow the quantitation of events in the more complex environment of a cell or organism.  Quantitative analysis can now be performed on cellular events and phenotypic changes.  This review will provide an overview of technologies and techniques that contribute to the drug discovery process.


Instructor and Moderator: Jared Amuan, Field Applications Scientist, Biotek Instruments

Biotek Instruments is a global leader in the development, manufacturing and sales of microplate instrumentation and software use aid in the advancement of life science research and facilitate the drug discovery process.  Prior to joining Biotek, Jared has held positions at Genemachine and Genset SA working on within the field of Genomics analysis and automation.  He received a BS of Science from Seattle University and holds an MBA from Boston University.

Post has attachment
“design is an exact science”
a science that can answer any question within its rigorous and exact results, measurable, reproducible  and can be  expressed in an analytical and objective.
a science that has methodological rigor and exact results.
-Acquacalda Experimental Design Group
Hb believes that good design in workspaces inspires creativity. New York City abounds with a magical creative energy like no other place in the world. We believe that entrepreneurs starting a biotech company here can be inspired by NYC itself and the designers, artists and makers who call NYC home.
We have taken great care to include furnishings and design by New York City based makers in Harlem Biospace. We are also featuring NYC designers in our Hb Design Store.   Come meet the designers and makers that made Harlem Biospace and hear about what inspires their creative process.

Post has attachment
Join the Harlem Biospace member companies and our guest instructor Scott Levitt for a lecture and discussion on preparing documents to present your science based venture to investors. 

Instructor and Moderator

Scott Levitt, Associate, Roberts Mitani Life Science Investment Group

Associate RMA, holds 6 years of experience specializing in biomedical R&D and process engineering. Scott focuses on identifying, analyzing, and evaluating the technology, market opportunity, clinical data, and financials of companies in the life science and healthcare sectors.

Prior to Roberts Mitani, Scott worked with Innovia and Syntheon on devices with applications in cardiology, endocrinology, ophthalmology, orthopedics, and minimally invasive surgery. He conducted clinical research and co-authored a paper at the Hospital of the University of Pennsylvania as well as developed several devices and systems to support interventional cardiology procedures. Additionally, Scott served as a teaching assistant at the University of Pennsylvania for a number of courses covering the fundamentals of high-tech startups including developing strategies for product positioning, marketing, distribution, sales, operations, management and financing.

Scott received his Bachelor of Science in Engineering in Bioengineering and Engineering Entrepreneurship from the School of Engineering and Applied Sciences at the University of Pennsylvania.

Post has attachment
Join the Harlem Biospace member companies and our guest instructor Andrew Hessel for a lecture and discussion on the current and future capability of sythetic biology techniques. 


Instructor and Moderator

Andrew Hessel, Distinguished Researcher, Autodesk

Andrew is a thought leader for development of biological technologies, helping industry, academics, and authorities better understand the changes ahead in life science. He is also the co-founder of the Pink Army Cooperative, the world’s first cooperative biotechnology company, which is aiming to make open source viral therapies for cancer.

Trained in microbiology and genetics, Andrew has continually worked at the forefront of genomics, first to read and comprehend bacterial, human, and other genomes and more recently to write them. He believes the technology that makes this possible, called synthetic biology, is revolutionary and that it will eventually surpass information technology (IT) as an economic engine and driver of societal change. He speaks widely on topics that include cells as living computers, life science as an emerging IT industry, and biological safety and security.

Andrew is an advocate of open genetic engineering, believing that the field will increasingly resemble the software industry and give rise to open source, single purpose (app), and ‘freemium’ applications, and that it will be spearheaded by younger programmer-entrepreneurs. He is active in the iGEM and DIYbio (do-it-yourself) communities and frequently works with students and young entrepreneurs to help them be successful.

Andrew is faculty in Bioinformatics and Biotechnology at the Singularity University, based at NASA Research Park in Mountain View, California. There, he educates graduate students and executive participants on the disruptive shifts underway in life science and helps them become actively engaged in these areas. He is a fellow at the University of Ottawa, Institute for Science, Society, and Policy, focusing on how next-generation technologies shape society’s future.
Wait while more posts are being loaded